Citadel Advisors
BLRX

Citadel Advisors’s BioLineRX BLRX Stock Holding History

Citadel Advisors’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,600
Closed -$33.1K – 13012
2025
Q4 		$33.1K Buy
+11,600
New +$40.1K ﹤0.01% 12195
2025
Q3 		– Sell
-43,500
Closed -$199K – 12786
2025
Q2 		$199K Buy
+43,500
New +$161K ﹤0.01% 10689
2025
Q1 		– Sell
-1,878
Closed -$16K – 14504
2024
Q4 		$16K Buy
1,878
+715
+61% +$10.5K ﹤0.01% 13331
2024
Q3 		$24.9K Sell
1,163
-85
-7% -$2.33K ﹤0.01% 12606
2024
Q2 		$28.2K Buy
1,248
+645
+107% +$17.3K ﹤0.01% 12327
2024
Q1 		$27K Sell
603
-307
-34% -$15.4K ﹤0.01% 12788
2023
Q4 		$57.1K Sell
910
-1,568
-63% -$97K ﹤0.01% 11641
2023
Q3 		$180K Buy
2,478
+1,358
+121% +$91.3K ﹤0.01% 10089
2023
Q2 		$71.5K Buy
+1,120
New +$62K ﹤0.01% 11369
2022
Q3 		– Sell
-258
Closed -$13K – 12630
2022
Q2 		$13K Sell
258
-17
-6% -$945 ﹤0.01% 12520
2022
Q1 		$19K Sell
275
-253
-48% -$17.6K ﹤0.01% 13250
2021
Q4 		$43K Buy
+528
New +$55K ﹤0.01% 13322
2021
Q3 		– Sell
-688
Closed -$77K – 13806
2021
Q2 		$77K Buy
+688
New +$80.9K ﹤0.01% 13098

Other funds holding BLRX

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
BCV
Banque Cantonale Vaudoise Lausanne, Switzerland $722M AUM 30.45% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.21B AUM 33.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Citadel Advisors's BLRX Position: Q2 2026 in Review

Citadel Advisors opened a new position in BioLineRX (BLRX) in Q2 2026: 14,796 shares worth $45.9K. The stake represents ﹤0.01% of the portfolio and ranks #13156 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in BLRX as recently as Q4 2025.

Citadel Advisors first reported a position in BLRX in Q1 2014 and has held it in 21 quarters since. The position peaked at $451K in Q3 2021. 14 funds tracked by Wall St. Rank hold BLRX as of Q2 2026.

  • Citadel Advisors held 14,796 shares of BioLineRX worth $45.9K as of Q2 2026.
  • BioLineRX was a new Citadel Advisors position in Q2 2026.
  • BioLineRX made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13156 holding.
  • Citadel Advisors first reported a position in BioLineRX in Q1 2014 and has held it in 21 quarters since.
  • Citadel Advisors's BioLineRX position peaked at $451K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held BioLineRX as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.